Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB-AOOE Cause Finger deformity? 395 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 395 reports of Finger deformity have been filed in association with ERENUMAB-AOOE. This represents 0.8% of all adverse event reports for ERENUMAB-AOOE.

395
Reports of Finger deformity with ERENUMAB-AOOE
0.8%
of all ERENUMAB-AOOE reports
394
Deaths
388
Hospitalizations

How Dangerous Is Finger deformity From ERENUMAB-AOOE?

Of the 395 reports, 394 (99.7%) resulted in death, 388 (98.2%) required hospitalization, and 387 (98.0%) were considered life-threatening.

Is Finger deformity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 395 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB-AOOE Cause?

Accidental exposure to product (9,923) Device difficult to use (9,530) Wrong technique in product usage process (9,359) Drug dose omission by device (6,340) Migraine (4,290) Drug ineffective (3,813) Constipation (3,104) Product storage error (2,958) Headache (2,787) Injection site pain (2,715)

What Other Drugs Cause Finger deformity?

ETANERCEPT (1,293) ADALIMUMAB (1,260) METHOTREXATE (1,003) LEFLUNOMIDE (798) RITUXIMAB (731) TOFACITINIB (707) ABATACEPT (663) TOCILIZUMAB (622) SECUKINUMAB (606) HYDROXYCHLOROQUINE (550)

Which ERENUMAB-AOOE Alternatives Have Lower Finger deformity Risk?

ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE ERENUMAB-AOOE vs ERGOCALCIFEROL ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB-AOOE vs ERIBULIN ERENUMAB-AOOE vs ERLOTINIB

Related Pages

ERENUMAB-AOOE Full Profile All Finger deformity Reports All Drugs Causing Finger deformity ERENUMAB-AOOE Demographics